The Orphan Drugs Market is set to Rise as a Result of Pharma Companies Looking to Orphan Drugs as Essential Revenue
The EMA lifted restrictions on providing fee reductions to large companies developing new orphan drugs and the Early Access to Medicines Scheme was introduced. LONDON, UNITED KINGDOM, May 20, 2014 /EINPresswire.com/ -- As of January 2014, the EMA lifted …